Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Veterinary Rapid Syndromic Polymerase Chain Reaction (PCR) Panels Market CAGR Outlook And Future Development
The veterinary rapid syndromic polymerase chain reaction (PCR) panels market has observed substantial growth in its size over recent years. It will grow from $1. 22 billion in 2025 to $1. 31 billion in 2026 at a compound annual growth rate (CAGR) of 7. 5%. This historical expansion is attributable to factors such as zoonotic disease outbreaks increasing diagnostic requirements, the rise of intensive livestock farming systems, increased expenditure on companion animal healthcare, the limitations inherent in conventional culture-based diagnostic methods, and heightened awareness regarding antimicrobial resistance concerns.
The veterinary rapid syndromic polymerase chain reaction (PCR) panels market size is anticipated to experience substantial growth in the coming years. It is projected to expand to $1.77 billion by 2030, achieving a compound annual growth rate (CAGR) of 7.8%. This expansion over the forecast period is attributable to several factors, including the increasing availability of AI-assisted diagnostic interpretation tools, a rise in the adoption of precision veterinary medicine approaches, regulatory enforcement of antimicrobial stewardship programs, growing demand for decentralized rapid testing solutions, and the integration of high-throughput multiplex molecular diagnostics into veterinary workflows. Prominent trends for the forecast period involve the expansion of point-of-care rapid molecular diagnostic testing in veterinary clinics, a growing acceptance of syndromic pathogen detection for early disease differentiation in animals, increasing demand for multiplex PCR assays to reduce diagnostic turnaround time, a heightened emphasis on diagnostic decision-making driven by antibiotic stewardship, and the broadening of centralized veterinary reference laboratory testing networks.
Get A Free Sample Report With In-Depth Market Insights:
Veterinary Rapid Syndromic Polymerase Chain Reaction (PCR) Panels Market Demand Drivers Opening New Revenue Streams
The expanding occurrence of infectious diseases in animals is projected to fuel the growth of the veterinary rapid syndromic polymerase chain reaction (PCR) panels market. These animal illnesses are caused by pathogenic microorganisms invading animal hosts, capable of spreading directly or indirectly among animals or from animals to humans. The surge in infectious disease prevalence among animals stems from increased animal population density, which facilitates quicker pathogen transmission and dispersal through closer contact. Veterinary rapid syndromic PCR panels assist in detecting these infectious diseases by enabling swift and precise identification of multiple pathogens simultaneously, thereby aiding early diagnosis, prompt treatment, and effective disease management. For instance, in November 2023, the Colorado Department of Agriculture, a US-based state government agency overseeing animal health, reported canine infectious respiratory disease cases that were double the levels typically observed during a standard outbreak period, with similar spikes documented across at least 10 U. S. states between 2022 and 2023. Consequently, the rising prevalence of infectious diseases in animals is propelling the expansion of the veterinary rapid syndromic polymerase chain reaction (PCR) panels market. The growing ownership of companion animals is anticipated to drive the expansion of the veterinary rapid syndromic polymerase chain reaction (PCR) panels market in the future. Companion animal ownership describes the practice of individuals or households keeping domesticated animals like dogs and cats as pets, establishing bonds that involve providing healthcare and veterinary services. This increasing trend of companion animal ownership is primarily influenced by evolving societal perspectives, where pets are increasingly viewed as family members, motivating more households to adopt animals and invest in their overall well-being, including health monitoring and disease management. Veterinary rapid syndromic PCR panels enable fast, accurate multi-pathogen detection in companion animals, facilitating early diagnosis, targeted treatment, and enhanced overall pet care. For instance, in December 2024, the American Veterinary Medical Association (AVMA), a US-based nonprofit organization and leading authority on veterinary medicine, stated that the total population of pet dogs in the United States reached 89. 7 million in 2024, a rebound from 80. 1 million in 2023, showing an increase of approximately 9. 6 million dogs within a single year. Therefore, growing companion animal ownership is fueling the growth of the veterinary rapid syndromic polymerase chain reaction (PCR) panels market.
Veterinary Rapid Syndromic Polymerase Chain Reaction (PCR) Panels Market Segmentation: How Does The Market Break Down By Category?
The veterinary rapid syndromic polymerase chain reaction (pcr) panels market covered in this report is segmented –
1) By Product Type: Respiratory Panels, Gastrointestinal Panels, Vector-Borne Disease Panels, Other Product Types
2) By Animal Type: Companion Animals, Livestock, Other Animal Types
3) By Component: Test Kits, Reagents And Master Mixes, Sample Collection Swabs And Tubes, Laboratory Consumables, Instruments And Equipment
4) By End User: Veterinary Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Other End Users
Subsegments:
1) By Respiratory Panels: Canine Respiratory Pathogen Panel, Feline Respiratory Pathogen Panel, Equine Respiratory Pathogen Panel, Avian Respiratory Pathogen Panel, Multi Species Respiratory Pathogen Panel
2) By Gastrointestinal Panels: Canine Gastrointestinal Pathogen Panel, Feline Gastrointestinal Pathogen Panel, Bovine Gastrointestinal Pathogen Panel, Swine Gastrointestinal Pathogen Panel, Multi Species Gastrointestinal Pathogen Panel
3) By Vector-Borne Disease Panels: Tick Borne Disease Panel, Flea Borne Disease Panel, Mosquito Borne Disease Panel, Canine Vector Borne Disease Panel, Multi Species Vector Borne Disease Panel
4) By Other Product Types: Neurological Disease Panel, Dermatological Infection Panel, Reproductive Disease Panel, Urinary Tract Infection Panel, Zoonotic Disease Panel
Veterinary Rapid Syndromic Polymerase Chain Reaction (PCR) Panels Market Trends Powering Strategic Industry Growth
Leading companies in the veterinary rapid syndromic polymerase chain reaction (PCR) panels market are concentrating on developing swift, multiplex PCR-based veterinary diagnostics to enhance overall animal health outcomes. These rapid, multiplex PCR-based veterinary diagnostics are molecular testing methods designed to promptly identify multiple pathogens in animal samples concurrently, thereby facilitating precise diagnosis and timely treatment decisions. For instance, in June 2025, bioMérieux, a France-based in vitro diagnostics company, introduced the VETFIRE PCR kit specifically for testing equine infectious respiratory diseases. This introduction utilizes the BIOFIRE SPOTFIRE System to offer rapid, point-of-care detection of seven respiratory pathogens in horses, providing highly accurate results in less than 20 minutes. The system operates with a simple nasopharyngeal swab, which supports informed veterinary choices for the treatment, isolation, and management of suspected infections. The convergence of advanced PCR technology with the SPOTFIRE platform allows for quicker outbreak containment, betterment of equine health management, and provides a scalable, user-friendly solution for both routine and competition-related health screenings across the United Kingdom, Ireland, and France.
Veterinary Rapid Syndromic Polymerase Chain Reaction (PCR) Panels Market Company Landscape And Competitive Strategy
Major companies operating in the veterinary rapid syndromic polymerase chain reaction (pcr) panels market are Thermo Fisher Scientific Inc., Zoetis Inc., bioMérieux SA, IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., QIAGEN N. V., Neogen Corporation, Seegene Inc., Bioneer Corporation, Molbio Diagnostics Private Limited, Sansure Biotech Inc., INDICAL BIOSCIENCE GmbH, Royal GD, GeneReach Biotechnology Corp., Ring Biotechnology Co. Ltd., Biomeme Inc., BioNote Inc., Agrolabo S. p. A., Genekam Biotechnology AG, MEGACOR Diagnostik GmbH
View The Full Veterinary Rapid Syndromic Polymerase Chain Reaction (PCR) Panels Market Report:
Veterinary Rapid Syndromic Polymerase Chain Reaction (PCR) Panels Market Largest Region: Which Geography Holds The Highest Market Share?
North America was the largest region in the veterinary rapid syndromic polymerase chain reaction (PCR) panels market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary rapid syndromic polymerase chain reaction (PCR) panels market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.